Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Mortality caused by chronic liver disease in setting of diabetes continues to rise

Key clinical point: Age-standardized cirrhosis and hepatocellular carcinoma–related mortality among individuals with diabetes increased annually during the recent decade.

Major finding: Among individuals who had diabetes listed on their death certificate, the age-standardized mortality for cirrhosis and hepatocellular carcinoma as an underlying cause of death increased from 2007 to 2017 with an annual rate of 1.2% and 1.9%, respectively.

Study details: An analysis of 48,761 individuals with chronic liver disease as the underlying cause of death according to the National Vital Statistic System database.

Disclosures: One of the study authors was supported by the National Institutes of Health.


Kim D et al. Clin Gastroenterol Hepatol. 2019 Jun 17. doi: 10.1016/j.cgh.2019.06.011.